The aim of BEAT is to conduct comprehensive research mainly on:
the molecular mechanisms of two common neurological disorders; epilepsy and autism,
new therapeutic targets for the cure of epilepsy and autism
implementation of behavioral and cognitive tests on laboratory animals,
behavioral and cognitive comorbidities in neurological disorders, and
new biomarkers for epilepsy and autism